HBV-ACLF – Medxy AI

This longitudinal single-cell multiomics study delineates the evolving immune landscape in HBV-ACLF, identifying key immune cell subsets and signaling pathways that drive disease progression and highlight potential therapeutic targets for precision medicine.

Targeting the TRPV4-RhoA-RhoGDI1 Axis: A Novel Approach for Hypertension Therapy
Rethinking the ‘Five a Day’: Why More Fruits and Vegetables Could Mean a Healthier Life
Debunking 10 Common Nutrition Myths: Insights from Longevity Experts
Surgical Management of Left-Sided Infective Endocarditis: Insights from the Nationwide NIDUS Registry
The Dawn of the “No-Clinical-Trial” Era for Biosimilars: FDA’s Historic Ustekinumab Approval Shift

About us
Contact us
MedXY story
Privacy Policy
Subscribe Now!
账号

English
日本語
Tiếng Việt
中文

aging AI Alzheimer's disease artificial intelligence atrial fibrillation blood pressure breast cancer cardiovascular health cardiovascular risk clinical trial COVID-19 depression diabetes diet dinh dưỡng exercise health heart failure HFpEF Hypertension immunotherapy longevity MASLD mental health Mortality NAFLD nutrition obesity Pregnancy prevention public health randomized controlled trial randomized trial sexual health sleep stroke Suy Tim sức khỏe tim mạch thử nghiệm lâm sàng treatment type 2 diabetes weight loss wellness women's health 心力衰竭

Your health, we care

Scroll to Top